T1	p 61 114	bestatin of acute nonlymphocytic leukemia in adults .
T2	p 146 162	bestatin ( INN :
T3	p 390 414	maintenance chemotherapy
T4	p 419 456	adult acute nonlymphocytic leukemia (
T5	p 518 528	, patients
T6	p 628 648	101 eligible cases (
T7	p 927 949	the 15-49 yr age group
T8	p 955 977	the 50-65 yr age group
T9	p 1061 1083	immunotherapy of adult
T10	p 1151 1169	elderly patients ,
T11	i 37 69	chemoimmunotherapy with bestatin
T12	i 121 143	immunomodulating agent
T13	i 146 154	bestatin
T14	i 163 171	Ubenimex
T15	i 337 359	bestatin immunotherapy
T16	i 380 389	remission
T17	i 402 414	chemotherapy
T18	i 552 560	bestatin
T19	i 587 597	po ) daily
T20	i 700 708	bestatin
T21	i 879 887	bestatin
T22	i 1008 1016	Bestatin
T23	o 499 517	complete remission
T24	o 582 584	os
T25	o 731 740	remission
T26	o 803 811	survival
T27	o 826 851	prolongation of remission
T28	o 1114 1136	survival and remission